Oncology research and product development.
Miles Deep Research has expanded into applied AI systems for education and business workflows while retaining oncology as a dedicated research vertical.
This page preserves the company’s oncology product-development history and research interests separate from the AI services now featured on the main site.
Development of
Oncology Products
A deep research company in the preclinical areas of cell differentiation and targeted therapy deployment methods. Leveraging Machine Learning and other data models with technology of CRISPR/CAS9 and TALENS.
Investor Opportunities
We have a wide range of investor opportunities with a minimum investment of $150,000. Funding rounds are 2023 – 2025.
About Miles Deep Research LLC. (MDR)
Founded in 2021, Products expected in 2026
Joseph E. Miles, an entrepreneur based in Austin TX with decades of experience in insurance, technology and education industries. After close family diagnoses involving Fallopian Tube and Non Small Cell Lung Cancer, Joseph began oncology initiatives in 2013; with ramp ups in 2017 and the creation of Miles Deep Research LLC. in 2021. Combining private-sector product discipline with research-oriented staff and partnerships, Miles Deep Research continues to maintain oncology and pharmaceutical product development as a focused research vertical.
Miles Deep Research LLC. (MDR) Founder
Our FOCUS
What We Are Developing
Miles Deep Research (MDR) focuses on product development above all.